During the past decade, General Teaching Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "General Teaching Hospital" #1 sponsor was "Czech Lymphoma Study Group" with 2 trials, followed by "Lung Biotechnology PBC" with 2 trials sponsored, "Charles University, Czech Republic" with 1 trials sponsored, "General University Hospital, Prague" with 1 trials sponsored and "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "General Teaching Hospital" #1 collaborator was "Amicus Therapeutics" with 1 trials as a collaborator, "Charles University, Czech Republic" with 1 trials as a collaborator and "Klinické centrum ISCARE" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "General Teaching Hospital" are "Pulmonary Arterial Hypertension" (2 trials), "Adult" (1 trials), "Fabry Disease" (1 trials), "Lymphoma, T-Cell, Peripheral" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "General Teaching Hospital" in a lesser frequency.

Most popular intervention types in "General Teaching Hospital" are "Drug" (3 trials), "Other" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Beraprost Sodium Modified Release" (2 trials), "Adcetris 50 MG Injection" (1 trials), "Doxorubicin" (1 trials), "Endoxan" (1 trials) and "Etoposide" (1 trials). Other intervention names were less common.

The vast majority of trials in "General Teaching Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "General Teaching Hospital". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in General Teaching Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in General Teaching Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".